Riluzole is a glutamate release inhibitor that modulates neuronal excitability by blocking voltage-dependent sodium channels and reducing glutamate neurotransmission. In Visual Snow Syndrome, it may help reduce cortical hyperexcitability and potentially alleviate the persistent visual disturbances by stabilizing neuronal activity and decreasing excessive neural signaling.